JOINT VENTURE WITH YAFO CAPITAL, LTD.
With the idea to have representatives for licensing transactions in Europe and in China, FCF Life Sciences formed a joint venture with Yafo Capital, Ltd. in 2019. Together, we form a unique team to address the needs of our European and Asian clients. Our aim is to facilitate and guarantee a smooth partnering process.
Facts on Yafo Capital, Ltd.
- Shanghai based advisory firm
- Established network and access to leading 200+ Pharma and MedTech companies in Asia
- Team of 20+ professionals with banking and healthcare background
- ~20 completed transactions within the last five years
ACCESS CHINA FORUM
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable business development opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
UPCOMING EVENT
FCF Automotive Supplier Market Study – 2024 published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF AUTOMOTIVE SUPPLIER MARKET STUDY – 04/2024”.
Based on available data from European automotive suppliers, the FCF AUTOMOTIVE SUPPLIER MARKET STUDY is a detailed and comprehensive analysis of the automotive supplier sector and especially addresses the European small/midcap market segment.
Key findings of the FCF Automotive Supplier Market Study are:
- Revenues are expected to increase by 1.0% from ’23 to ’24, after an increasing by 5.2% in ’23
- EBITDA is expected to increase by 20.4% from ’23 to ’24, after increasing by 4.7% in ’23
- EBIT is expected to increase by 19.2% from ’23 to ’24, after increasing by 14.5% in ’23
- EV / EBITDA valuation decreased from 7.1x in ’22 to 6.4x in ’23
- EV / EBIT valuation decreased from 11.6x in ’22 to 9.4x in ’23
- EBITDA margin remained constant at 13.3% in ’22 and ’23
- Net leverage ratio decreased from 2.6x in ’22 to 2.2x in ’23
- Implied Credit Rating remained constant at BXX in ’22 and ‘23
To access the full report, please click here.
By Kai Frömert, Marcel Lange, Tristan Blümli, Marco Buonafede Bennardo and Yasmin Herrmann
